These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7316178)

  • 21. Synthesis of an affinity chromatography gel for AT III. Effect of purification of AT III-binding sequence of heparin.
    Tomono T; Igarashi S; Sawada E
    Thromb Res; 1984 Aug; 35(4):467-73. PubMed ID: 6484894
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule.
    Niewiarowski S; Rucinski B; James P; Lindahl U
    FEBS Lett; 1979 Jun; 102(1):75-8. PubMed ID: 456593
    [No Abstract]   [Full Text] [Related]  

  • 25. From heparin to heparin fractions and derivatives.
    Coyne E
    Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
    Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
    J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N; Kikuchi M; Yosizawa Z
    Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-angle x-ray scattering of high- and low-affinity heparin.
    Khorramian BA; Stivala SS
    Arch Biochem Biophys; 1986 Jun; 247(2):384-92. PubMed ID: 3717950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III and heparin.
    Barrowcliffe TW; Johnson EA; Thomas D
    Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
    [No Abstract]   [Full Text] [Related]  

  • 32. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
    Soons H; Tans G; Hemker HC
    Biochem J; 1988 Dec; 256(3):815-20. PubMed ID: 3265623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The N-terminal segment of antithrombin acts as a steric gate for the binding of heparin.
    Fitton HL; Skinner R; Dafforn TR; Jin L; Pike RN
    Protein Sci; 1998 Mar; 7(3):782-8. PubMed ID: 9541411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heparin and heparin fractions on platelet aggregation.
    Salzman EW; Rosenberg RD; Smith MH; Lindon JN; Favreau L
    J Clin Invest; 1980 Jan; 65(1):64-73. PubMed ID: 6243142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro.
    Kulane A; Ekre HP; Perlmann P; Rombo L; Wahlgren M; Wahlin B
    Am J Trop Med Hyg; 1992 May; 46(5):589-94. PubMed ID: 1599053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement.
    Olson ST; Shore JD
    J Biol Chem; 1981 Nov; 256(21):11065-72. PubMed ID: 7287751
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.